A Drug-Drug Interaction Study to Study the Effect of AZD1981 on Warfarin

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Pharmakokinetic
Interventions
DRUG

AZD1981

100 mg per oral, twice daily for 14 days

DRUG

Warfarin

10 x 2.5 mg per oral, once daily at day 1 and day 15

DRUG

AZD1981

4 x 100 mg per oral, twice daily for 14 days

Trial Locations (1)

Unknown

Research Site, Uppsala

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY